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Abstract
Background: Research turnover in the HIV field is rapid, and as a result, maintaining high-quality, up-to-date, and
relevant systematic reviews is a challenge. One approach is to frequently update published reviews.
Methods: We evaluated the methods and relevance of all HIV systematic reviews and protocols published in the
Cochrane Library over a 16-year period (2000–2016) to determine the need to update published reviews or complete
of reviews in progress.
Results: Of 148 published reviews and protocols, 129 (87%) were identified as not for updating or progression to
publication, mostly due to research questions which were either entirely outdated or addressed questions in an
outdated manner (N = 89; 60%); this was anticipated for older reviews, but was found also to be the case for recent
publications. Some research questions were also inadequately conceptualized, particularly when complex pragmatic
trials or behavioral interventions were included.
Conclusions: We suggest that authors clearly characterize interventions and synthesis approaches in their review
protocols. In research fields, such as HIV, where questions change frequently, systematic reviews and protocols should
be regularly re-evaluated to ensure relevance to current questions. This process of re-evaluation should be incorporated
into the methods of living systematic reviews.
Background
The HIV field has high research outputs, and the cycle
of questions, trials, and guideline modification is rapid.
This raises the question of how to keep HIV systematic
reviews up to date, relevant, and derived from the high-
est methodological standards [1, 2]. One approach is to
regularly update reviews to incorporate new findings;
and indeed, some questions endure and should be up-
dated; and for others however, the review question may
have been answered, changed substantially, or become
irrelevant, and blindly updating such reviews can result
in wasted effort and resources. To provide insight into
how review questions change over time, we formally ap-
praised the relevance, methods, and need to update a
suite of HIV systematic reviews and protocols published
in the Cochrane Library between 2000 and 2016.
Methods
Between 1 May 2016 and 30 May 2018, we critically ap-
praised all published Cochrane HIV reviews and proto-
cols based on the Cochrane Updating Classification
System [3, 4]. The Updating Classification System acts
as a guide to readers to assess whether a review is up to
date, needs updating, or might need updating in the fu-
ture [3, 4]. We modified the tool for assessing protocols.
Reviews and protocols were appraised by evaluating: (a)
the currency and priority of the review question
(through discussion with experts in the field and explor-
ing the literature), (b) the methods, by using an abbrevi-
ated version of the MECIR standards [2], and (c)
whether there were new studies to be included in the re-
view, or whether another high-quality review had already
been published on the topic outside of Cochrane. Based
on the outcome of this assessment, we determined
whether reviews should be updated, and whether
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protocols should continue to full reviews. We catego-
rized them as follows: (1) continue with review update
or allow protocol to progress to full review and (2) not
for update or protocol progression due to (a) methodo-
logical concerns, (b) outdated research question, or (c)
review already up to date. At least two people read and
appraised each review independently, and the classifica-
tion was agreed in team meetings chaired by experi-
enced systematic review authors. The tool is available in
the Additional file 1.
Results
We identified and appraised 109 Cochrane HIV reviews
and 39 HIV protocols (148 articles in total), published
on the Cochrane Database of Systematic Reviews be-
tween 2000 and 2016. Review and protocol topics in-
cluded questions about HIV treatment interventions
(63%), HIV prevention interventions (32%), health sys-
tem interventions (2%), and interventions to improve
HIV diagnosis (3%). The majority of reviews (N = 98;
66%) were published between 2010 and 2016, with a
smaller proportion published between 2000 and 2009
(N = 50; 34%). We concluded that 19 (13%) of all reviews
and protocols were eligible for an update or progression
to full review, and the remaining 129 (87%) were
assessed as “not for updating or progression”.
Of the 109 published systematic reviews, 95 were
assessed as “not for updating” (87%). Of these, 62% had
outdated research questions (Fig. 1) where the intervention
was superseded by a superior intervention or by another
more up-to-date review, or where questions were already
answered, and there was little to no ongoing research in the
topic area. For example, a review of the “Effectiveness of
first-line tenofovir, emtricitabine and efavirenz for patients
with HIV” would not require updating as this question has
been answered. Another example is the use of HSV-2 sup-
pressive therapy for HIV prevention: this is no longer con-
sidered an option for HIV prevention; although there may
be some additional studies for inclusion, updating such a
review would be of little value to consumers or policy
makers. We discontinued 11 reviews due to methodological
errors (37%): this was the result of inadequately conceptual-
ized research questions (the population, interventions,
comparison, or outcomes were not sufficiently character-
ized or relevant). Sometimes, this led to “empty” reviews
(with no included studies after searches were conducted).
Another methodological problem was review questions
which were not unique to HIV populations, for example,
reviews evaluating drug effects in HIV subpopulations with
no clear rationale for why these agents would have different
outcomes in HIV-positive people.
Thirty-four of 39 protocols were stopped from pro-
gressing to full reviews (87%) (Fig. 1). The two main rea-
sons for discontinuation also included outdated research
questions. This included protocols where the topic was
no longer relevant to policy makers or consumers, or
where an important HIV research area was evaluated
but the protocol review question did not reflect current
Fig. 1 Outcomes of review and protocol appraisals
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practices or thinking. The remaining protocols were dis-
continued due to methodological limitations, as a result
of inadequately conceptualized research questions. Spe-
cifically, protocols encompassed a very broad set of
treatment strategies that were difficult to combine in
one review, or authors did not consider how to mean-
ingfully combine complex HIV interventions. This was
common in protocols which included behavioral HIV
prevention interventions and pragmatic implementation
trials. Thirty protocols were published more than 2 years
previously (interquartile range 3–9 years).
Discussion
This appraisal of Cochrane systematic reviews and pro-
tocols demonstrates that topics in the HIV field become
outdated quickly, and this was by far the commonest
reason for discontinuation of both reviews and proto-
cols, including those from more recent years. In
addition, changes in reporting standards over time re-
sulted in outdated methodology. Protocols which pro-
gressed slowly became irrelevant before completion, and
inadequately conceptualized research questions resulted
in disorganized or empty reviews which, at times, did
not address issues specifically relevant to HIV popula-
tions, or sufficiently characterize interventions and key
HIV outcomes.
Evaluating the relevance of systematic reviews prior to
updating is essential in all fields but particularly import-
ant where there is rapid development of new innovations
and care strategies, as seen in HIV research. Where
there are delays, protocols should be re-evaluated and
adapted to ensure that final reviews answer current
questions. With the recent drive to automate and create
“living” systematic reviews with frequent updates [5, 6],
it is essential that methods of maintaining currency are
incorporated into these evidence synthesis approaches as
questions may change or become irrelevant [7, 8].
We recommend that authors planning to conduct HIV
systematic reviews reflect on how their review can con-
tribute, by thoroughly exploring the current evidence,
determining if primary studies exist on the topic of
interest, identifying other systematic reviews already
conducted, and clearly defining their research question
and what their review may add. In addition to presenting
the PICO (population, intervention, comparison, and
outcomes) elements, authors should fully characterize
the interventions of interest, limit the number and types
of interventions, and determine how to synthesize re-
sults from studies with behavioral or complex interven-
tions. Several available tools can be drawn on and
adapted to aid the design of conceptual frameworks and
characterization of interventions and complexity: this can
help structure review questions to produce meaningful re-
sults [7–11]. Review team effort and Cochrane editorial
procedures need to ensure timely completion of reviews
to avoid them being outdated before completion.
In summary, HIV research questions and the system-
atic reviews summarizing the relevant research evidence
become outdated quickly, and rapid conduct and publi-
cation is critical; clearly defined research questions need
to be regularly re-evaluated alongside changes in the
field to maintain relevance, particularly in the era of liv-
ing systematic reviews.
Additional files
Additional file 1: Modified tool for assessing reviews and protocols.
(DOCX 18 kb)
Abbreviations
HIV: Human immunodeficiency virus; HSV-2: Herpes simplex virus 2;
IQR: Interquartile range; MECIR: Methodological Expectations of Cochrane
Intervention Reviews
Acknowledgements
We would like to thank Taryn Young and Dierdre Walsh for facilitating this
work.
Funding
The work was funded by Cochrane CRG Support Programme in a grant
given to the Cochrane Infectious Diseases Group. The work of the Cochrane
Infectious Diseases Group is further funded by UK AID through the Research,
Evidence and Development Initiative (READ-It, project ID 300342–104). The
views expressed do not necessarily reflect the UK government’s official
policies.
Availability of data and materials
Data are available on request from Dierdre Walsh from the Cochrane Infectious
Diseases Group, Liverpool School of Tropical Medicine, Liverpool, United
Kingdom: Deirdre.Walshe@lstmed.ac.uk
Authors’ contributions
All authors contributed to the conduct of the review and protocol appraisal
and participated in the drafting and reviewing this manuscript. All authors
read and approved the final manuscript.
Authors’ information
None.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Center for Evidence Based Health Care, Division of Epidemiology and
Biostatistics, Department of Global Health, Stellenbosch University, Francie
Van Zyl drive, Cape Town 7505, South Africa. 2Cochrane Infectious Diseases
Group, Centre for Evidence Synthesis in Global Health, Liverpool School of
Tropical Medicine, Liverpool, UK. 3University of Central Lancashire, Lancashire,
UK. 4University of California, San Francisco, USA.
Eshun-Wilson et al. Systematic Reviews            (2019) 8:46 Page 3 of 4
Received: 9 November 2018 Accepted: 22 January 2019
References
1. Barroso J, Sandelowski M, Voils CI. Research results have expiration dates:
ensuring timely systematic reviews. J Eval Clin Pract. 2006; https://doi.org/
10.1111/j.1365-2753.2006.00729.x.
2. Higgins J, Lasserson T, Chandler J, Tovey D, Churchill R. Standards for the
conduct and reporting of new Cochrane Intervention Reviews, reporting of
protocols and the planning, conduct and reporting of updates. 2018.
Version 1.07. Accessed at: https://community.cochrane.org/mecir-manual.
3. Garner P, Hopewell S, Chandler J, et al. When and how to update
systematic reviews: consensus and checklist. BMJ. 2016;354:i3507 https://doi.
org/10.1136/bmj.i3507.
4. Cochrane Editorial Unit. Updating Classification System: guide to applying
to Cochrane reviews. 2016. Accessed at: https://community.cochrane.org/
editorial-and-publishing-policy-resource/cochrane-review-management/
updating-classification-system-cochrane-reviews.
5. Elliott JH, Synnot A, Turner T, et al. Living systematic review: 1. Introduction—the
why, what, when, and how. J Clin Epidemiol. 2017;91:23–30 https://doi.org/10.
1016/j.jclinepi.2017.08.010.
6. O’Connor AM, Tsafnat G, Gilbert SB, Thayer KA, Wolfe MS. Moving toward
the automation of the systematic review process: a summary of discussions
at the second meeting of International Collaboration for the Automation of
Systematic Reviews (ICASR). Syst Rev. 2018;7(1):3 https://doi.org/10.1186/
s13643-017-0667-4.
7. Hickey MD, Odeny TA, Petersen M, et al. Specification of implementation
interventions to address the cascade of HIV care and treatment in resource-
limited settings: a systematic review. Implement Sci. 2017;12(1):102 https://
doi.org/10.1186/s13012-017-0630-8.
8. Rohwer A, Pfadenhauer L, Burns J, et al. Series: clinical epidemiology in
South Africa. Paper 3: logic models help make sense of complexity in
systematic reviews and health technology assessments. J Clin Epidemiol.
2017;83:37–47. https://doi.org/10.1016/j.jclinepi.2016.06.012.
9. Guise JM, Chang C, Butler M, Viswanathan M, Tugwell P. AHRQ series on
complex intervention systematic reviews—paper 1: an introduction to a
series of articles that provide guidance and tools for reviews of complex
interventions. J Clin Epidemiol. 2017;90:6–10. https://doi.org/10.1016/j.
jclinepi.2017.06.011.
10. Proctor EK, Powell BJ, McMillen JC. Implementation strategies:
recommendations for specifying and reporting. Implement Sci. 2013;8(1):1–
11 https://doi.org/10.1186/1748-5908-8-139.
11. Lewin S, Hendry M, Chandler J, et al. Assessing the complexity of
interventions within systematic reviews: development, content and use of a
new tool (iCAT-SR). BMC Med Res Methodol. 2017;17(1):1–13 https://doi.org/
10.1186/s12874-017-0349-x.
Eshun-Wilson et al. Systematic Reviews            (2019) 8:46 Page 4 of 4
